State of New Jersey Common Pension Fund D raised its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 16.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 700,000 shares of the company’s stock after buying an additional 100,000 shares during the quarter. State of New Jersey Common Pension Fund D owned about 0.80% of Acadia Healthcare worth $33,432,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in the business. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Acadia Healthcare by 11.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock worth $134,000 after purchasing an additional 270 shares during the last quarter. C M Bidwell & Associates Ltd. acquired a new stake in shares of Acadia Healthcare during the second quarter worth $205,000. Riverhead Capital Management LLC acquired a new stake in shares of Acadia Healthcare during the second quarter worth $209,000. Paloma Partners Management Co acquired a new stake in shares of Acadia Healthcare during the first quarter worth $217,000. Finally, Rathbone Brothers plc acquired a new stake in shares of Acadia Healthcare during the third quarter worth $223,000.
COPYRIGHT VIOLATION NOTICE: “State of New Jersey Common Pension Fund D Has $33.43 Million Holdings in Acadia Healthcare Company, Inc. (ACHC)” was first reported by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.com-unik.info/2017/10/29/state-of-new-jersey-common-pension-fund-d-has-33-43-million-holdings-in-acadia-healthcare-company-inc-achc.html.
ACHC has been the topic of several analyst reports. Jefferies Group LLC set a $60.00 price objective on Acadia Healthcare and gave the stock a “buy” rating in a report on Wednesday, October 11th. BidaskClub cut Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Friday, August 18th. Citigroup Inc. decreased their price objective on Acadia Healthcare from $61.00 to $44.00 and set a “buy” rating on the stock in a report on Wednesday. Zacks Investment Research cut Acadia Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday, August 1st. Finally, Cantor Fitzgerald decreased their price objective on Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating on the stock in a report on Tuesday, October 24th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. Acadia Healthcare presently has a consensus rating of “Buy” and a consensus price target of $49.31.
Acadia Healthcare Company, Inc. (ACHC) opened at 33.25 on Friday. Acadia Healthcare Company, Inc. has a 52-week low of $30.91 and a 52-week high of $54.34. The stock has a market capitalization of $2.92 billion, a price-to-earnings ratio of 365.38 and a beta of 1.07. The firm has a 50-day moving average price of $44.40 and a 200 day moving average price of $46.07.
Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.07). Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The company had revenue of $716.70 million for the quarter, compared to analysts’ expectations of $728.86 million. During the same quarter in the prior year, the firm earned $0.58 earnings per share. The company’s revenue was down 2.4% on a year-over-year basis. On average, equities research analysts predict that Acadia Healthcare Company, Inc. will post $2.28 EPS for the current year.
In related news, EVP Christopher L. Howard sold 53,713 shares of the company’s stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $2,722,711.97. Following the completion of the sale, the executive vice president now directly owns 147,286 shares in the company, valued at $7,465,927.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William Grieco sold 2,000 shares of the company’s stock in a transaction on Friday, August 11th. The stock was sold at an average price of $51.71, for a total transaction of $103,420.00. Following the completion of the sale, the director now owns 45,013 shares of the company’s stock, valued at $2,327,622.23. The disclosure for this sale can be found here. Insiders sold 3,085,693 shares of company stock valued at $157,729,099 over the last quarter. 11.10% of the stock is currently owned by corporate insiders.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
What are top analysts saying about Acadia Healthcare Company Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Acadia Healthcare Company Inc. and related companies.